Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Aug;83(2):250-7.
doi: 10.4269/ajtmh.2010.09-0514.

Frequency distribution of antimalarial drug resistance alleles among Plasmodium falciparum isolates from Gezira State, central Sudan, and Gedarif State, eastern Sudan

Michela Menegon  1 , Albadawi A Talha, Carlo Severini, Sayed M Elbushra, Ahmed A Mohamedani, Elfatih M Malik, Tarig A Mohamed, Walther H Wernsdorfer, Giancarlo Majori, Bakri Y M Nour
Affiliations

Frequency distribution of antimalarial drug resistance alleles among Plasmodium falciparum isolates from Gezira State, central Sudan, and Gedarif State, eastern Sudan

Michela Menegon et al. Am J Trop Med Hyg. 2010 Aug.

Abstract

In 2004, Sudan adopted artesunate + sulfadoxine/pyrimethamine (SP) combination as the first-line drug, in response to the high level of falciparum resistance to antimalarials. In 2007, a molecular study on antimalarial resistance linked genes, pfcrt, pfmdr1, pfdhfr, pfdhps, and pfATPase6, was conducted on 198 isolates from central and eastern Sudan. We observed a high frequency of point mutations at almost all loci analyzed, mainly of pfcrt 76T (72.7%), pfdhfr 51I (75.3%), and pfdhfr 108N (72.7%) alleles. The MARK III in vitro test for chloroquine sensitivity in 45 P. falciparum isolates showed that 37.8% of the isolates were low resistant and 6.7% were fully resistant. This study represents the most recent molecular investigation on antimalarial resistance in this area after the adoption of artemisinin-based combination therapy (ACT), and underlines the importance of the analysis of SP resistance evolution to monitor the efficacy of ACT therapy in endemic areas.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Map of Sudan. On the right are the sites of this study. The geographical coordinates are indicated in the figure.
Figure 2.
Figure 2.
Overall prevalence of Sudanese isolates carrying point mutations observed in a total of eight codons in the pfcrt, pfmdrl, pfdhfr, and pfdhps genes.
See this image and copyright information in PMC

References

    1. Wellems T, Plowe C. Chloroquine-resistant malaria. J Infect Dis. 2001;184:770–776. - PubMed
    1. White NJ. Antimalarial drug resistance. J Clin Invest. 2004;113:1084–1092. - PMC - PubMed
    1. Wongsrichanalai C, Pickard AL, Wernsdorfer WH, Meshnick SR. Epidemiology of drug-resistant malaria. Lancet Infect Dis. 2002;2:209–218. - PubMed
    1. Hayton K, Su XZ. Genetic and biochemical aspects of drug resistance in malaria parasites. Curr Drug Targets Infect Disord. 2004;4:1–10. - PubMed
    1. Sisowath C, Stromberg J, Martensson A, Msellem M, Obondo C, Björkman A, Gil JP. In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem) J Infect Dis. 2005;191:1014–1017. - PubMed

Publication types

LinkOut - more resources